Siemens Healthcare Presents syngo.via RT Image Suite Software Solution

Siemens HealthcareAt the third forum of the European Society for Therapeutic Radiology and Oncology (ESTRO) in Barcelona, Siemens Healthcare will be presenting a new software solution for radiation therapy: syngo.via RT Image Suite has been specially developed to make it easier for radiation oncologists to evaluate a range of clinical images such as MRI, CT, PET-CT, and cone beam CT images, and to subsequently contour tumors and the surrounding organs to be spared. This means that the available image data, independent of the modality, can be used more effectively to define the optimal patient-specific radiation therapy strategy.

Today, existing software such as virtual simulation or treatment planning solutions are only partly able to accommodate the increasing number and diversity of images. Often, only two image series can be displayed at the same time - far too few if the clinician is looking to have a comprehensive view of the clinical situation using several different MRI contrasts, CT and PET images, and 3D and 4D views with the aim of deciding on the best-possible treatment approach.

This is different with the new syngo.via RT Image Suite. Based on syngo.via, Siemens' comprehensive image viewing and processing software solution, syngo.via RT Image Suite has been specifically developed to accommodate the increasing number and diversity of images used in radiation oncology: Up to eight fused image series can be displayed on up to four image panels at the same time. Dual Energy CT images, different PET tracers, and different MRI image contrasts - which are particularly helpful when diagnosing prostate cancer, for example - can be visualized at the same time, as can all image data for moving tumors, for example in the liver or lungs. Syngo.via RT Image Suite therefore offers radiation oncologists a detailed basis for deciding on the therapy approach, evaluating courses of treatment, and possibly adapting the treatment.

A well-founded assessment of clinical situation is just the first step on the path to more precise radiation therapy. The subsequent, exact contouring of the tumor plays just as important. Here, too, the syngo.via RT Image Suite helps by making it easier and quicker to contour the tumor tissue and neighboring organs, for example, via the automatic, parallel contouring of marked areas in several image series. Tumors can be quickly contoured, even in moving 4D CT datasets for the lungs. And if an adaption of therapy is required during the course of treatment, the software application supports fast re-contouring of the tumor boundaries.

Clinical images contoured using syngo.via RT Image Suite can then be transferred to treatment planning systems such as Eclipse from Varian Medical Systems - Siemens Healthcare's strategic partner in radiation therapy - for dosimetric planning. Particularly in curative approaches - which is increasingly the case in breast or prostate cancer patients, both constituting a large proportion of oncological diseases - precise radiation dose planning is extremely important to avoid side effects in neighboring organs, which are potentially at risk.

Syngo.via RT Image Suite is available with new imaging systems and also as an upgrade for installed Siemens Healthcare systems. In addition to clinical images from the various Siemens imaging modalities, diagnostic images from other manufacturers can also be viewed and processed.

Magnetom RT Pro edition supports MRI trend in radiation therapy planning
Magnetic resonance imaging (MRI) - due to its excellent soft-tissue contrast - is gaining importance as the basis for radiation therapy decisions. Therefore, Siemens Healthcare will also be presenting an innovation in this field at the ESTRO Forum: The Magnetom RT Pro edition encompasses an MRI scanner with a particularly spacious open bore of 70 centimeters - either the 1.5-tesla Magnetom Aera or the 3-tesla Magnetom Skyra - and special equipment for radiation oncology. This includes the RT Dot Engine, among others, whose protocols are specially tailored to radiation therapy workflows.

In addition, Siemens Healthcare will present the new RT Pro edition for the Somatom Definition AS Open computer tomograph - now with new functionalities. These include a new, highly effective iterative algorithm for metal artifact reduction: iMAR can significantly reduce disruptive image artifacts caused by implants, artificial joints or pacemakers, which are found in more and more patients. Therapies can therefore be prepared and dose calculated based upon much more detailed information for a larger number of radiation therapy patients.

About Siemens AG
Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for more than 165 years. The company is active in more than 200 countries, focusing on the areas of electrification, automation and digitalization. One of the world's largest producers of energy-efficient, resource-saving technologies, Siemens is No. 1 in offshore wind turbine construction, a leading supplier of combined cycle turbines for power generation, a major provider of power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry. The company is also a leading provider of medical imaging equipment - such as computed tomography and magnetic resonance imaging systems - and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2014, which ended on September 30, 2014, Siemens generated revenue from continuing operations of €71.9 billion and net income of €5.5 billion. At the end of September 2014, the company had around 343,000 employees worldwide on a continuing basis.

Most Popular Now

West Midlands to Digitally Transform Can…

NHS patients throughout the West Midlands are to benefit from a digital pathology programme, designed to help reduce cancer backlogs, transform services, and improve the speed and accuracy of cancer...

AI Transforms Smartwatch ECG Signals int…

A study published in Nature Medicine reports the ability of a smartwatch ECG to accurately detect heart failure in nonclinical environments. Researchers at Mayo Clinic applied artificial intelligence (AI) to...

Siemens Healthineers Splits Fast-Growing…

Siemens Healthineers is splitting its Asia Pacific operations into two to allow both China and the rest of the region to achieve their full potential. China, now its own region...

Siemens Healthineers Presents Two Revolu…

7 Tesla (T) Magnetom Terra.X(1) will offer excellent imaging of even the smallest structures 3T Magnetom Cima.X(2) more than doubles the gradient amplitude(3) AI algorithms which can reduce scanning...

3D Protein Structure Predictions Made by…

In a living being, proteins make up roughly everything: from the molecular machines running every cell's metabolism, to the tip of your hair. Encoded in the DNA, a protein may...

New Group to Advance Digital Twins in He…

EDITH (Ecosystem for Digital Twins in Healthcare) Coordination and Support Action (CSA) - a group made up of numerous internationally renowned research institutions, professional associations, companies, and hospitals of excellence...

Willingness to Use Video Telehealth Incr…

Americans' use and willingness to use video telehealth has increased since the beginning of the COVID-19 pandemic, rising most sharply among Black Americans and people with less education, according to...

Evaluating Use of New AI Technology in D…

Published in the Journal of the American Medical Informatics Association, University of Minnesota researchers led a study evaluating federated learning variations for COVID-19 diagnosis in chest x-rays. Federated learning is...

DMEA Call for Papers: Supporting Digital…

25 - 27 April 2023, Berlin, Germany. Health meets digitalisation: from 25 to 27 April 2023 at DMEA - Connecting Digital Health, all actors aiming to promote health IT will be...

Machine Learning can Help Predict Patien…

Predicting which patients will respond well to treatment is a quandary that has plagued the field of cancer immunotherapy for more than four decades. Now, researchers at the Johns Hopkins...

MEDICA 2022 and COMPAMED 2022: Internati…

14 - 17 November 2022, Düsseldorf, Germany. Next week sees the return of the date marked in extra thick outline in many yearly calendars of the international health and medical technology...

MEDICA and COMPAMED Present Themselves a…

14 - 17 November 2022, Düsseldorf, Germany. MEDICA and COMPAMED continue to develop in an extremely vital manner. The world's leading medical trade fair and the international No. 1 for the...